ABSTRACT
Escalating demands for limited food supplies at America's food banks and pantries during the COVID-19 pandemic have raised ethical concerns underlying "first-come, first-served" distributions strategies. A series of model ethical principles are designed to guide ethical allocations of these resources to assure greater access among persons facing food insecurity.
Subject(s)
Disaster Planning , Food Assistance/ethics , Guidelines as Topic , Resource Allocation/ethics , COVID-19/epidemiology , Emergencies , Food Assistance/organization & administration , Food Supply , Humans , Public Health , Resource Allocation/organization & administration , United StatesSubject(s)
Commerce , Communicable Disease Control/legislation & jurisprudence , Coronavirus Infections/epidemiology , Pneumonia, Viral/epidemiology , Public Policy/legislation & jurisprudence , Betacoronavirus , COVID-19 , Coronavirus Infections/prevention & control , Economics , Employment/legislation & jurisprudence , Freedom , Humans , Liability, Legal , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , Public Health , SARS-CoV-2 , United States/epidemiologySubject(s)
Nursing Informatics , Specialties, Nursing , Humans , Nurse's Role , Ohio , United StatesSubject(s)
Alkaline Phosphatase/blood , Amyloidosis/complications , Amyloidosis/pathology , Ascites/pathology , Hypertension, Portal/etiology , Liver Diseases/complications , Liver Diseases/pathology , Amyloidosis/diagnostic imaging , Ascites/diagnostic imaging , Humans , Liver Diseases/diagnostic imaging , Male , Middle Aged , Prealbumin/metabolism , Serum Amyloid A Protein/metabolism , Tomography, X-Ray ComputedABSTRACT
Liver biopsy has been used to diagnose chronic liver disease and to assess the degree of hepatic inflammation and fibrosis. However, it is an invasive test with many possible complications and the potential for sampling error. Noninvasive tests are increasingly precise in identifying the cause of many cases of liver disease and even the amount of liver injury (fibrosis). This review discusses the role of noninvasive tests to diagnose liver disease and to assess hepatic fibrosis and cirrhosis.
